Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Borobia AM, Carcas AJ, Perez-Olmeda M, Castano L, et al. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet 2021 Jun 25. pii: S0140-6736(21)01420.
PMID: 34181880


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016